Showing results (61-70 of 154) with videos related to
Sort By:
Pageof 16
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 27, 2009
Relation between elective nodal failure and irradiated volume in non-small-cell lung cancer (NSCLC) treated with radiotherapy using conventional fields and dosesNaoko Sanuki-Fujimoto, Minako Sumi, Yoshinori Ito, et al.Cancer Science|June 28, 2006
Association of the OGG1-Ser326Cys polymorphism with lung adenocarcinoma riskTakashi Kohno, Hideo Kunitoh, Kaoru Toyama, et al.Lung Cancer (Amsterdam, Netherlands)|November 27, 2024
Difference in efficacy of osimertinib between patients with EGFR-positive NSCLC with postoperative recurrence and those with de novo unresectable disease: A prospective, observational studyMasato Karayama, Takafumi Suda, Kiyotaka Yoh, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 12, 2002
Genetic polymorphism of CYP2A6 gene and tobacco-induced lung cancer risk in male smokersNoritaka Ariyoshi, Masami Miyamoto, Yuri Umetsu, et al.BMJ Open|June 1, 2018
Venous thromboembolism in patients with cancer: design and rationale of a multicentre, prospective registry (Cancer-VTE Registry)Yasuo Ohashi, Masataka Ikeda, Hideo Kunitoh, et al.Japanese Journal of Clinical Oncology|November 20, 2018
Nivolumab and stereotactic radiation therapy for the treatment of patients with Stage IV non-small-cell lung cancerShingo Miyamoto, Ryutaro Nomura, Kengo Sato, et al.Thoracic Cancer|September 5, 2019
High mortality and poor treatment efficacy of immune checkpoint inhibitors in patients with severe grade checkpoint inhibitor pneumonitis in non-small cell lung cancerMari Tone, Takehiro Izumo, Nobuyasu Awano, et al.Japanese Journal of Clinical Oncology|April 25, 2008
Efficacy and safety of pemetrexed in combination with cisplatin for malignant pleural mesothelioma: a phase I/II study in Japanese patientsKazuhiko Nakagawa, Koichi Yamazaki, Hideo Kunitoh, et al.Lung Cancer (Amsterdam, Netherlands)|January 14, 2020
Randomized phase II trial of adjuvant chemotherapy with docetaxel plus cisplatin versus paclitaxel plus carboplatin in patients with completely resected non-small cell lung cancer: TORG 0503Kaoru Kubota, Hideo Kunitoh, Takashi Seto, et al.Cancer Science|October 22, 2009
Phase I study of TLR9 agonist PF-3512676 in combination with carboplatin and paclitaxel in patients with advanced non-small-cell lung cancerKazuhiko Yamada, Masao Nakao, Chikara Fukuyama, et al.Pageof 16